Vesicular Glutamate Transporters in Astrocytes as Potential New Therapeutic Targets: Astrocyte-targeted Viral Vectors Expressing Inhibitory Nanobodies
Astrocytes, the main Central Nervous System (CNS) glial cell type, actively release transmitters, including glutamate, and thereby participate in physiological brain information processing. However, dysregulated transmitter release from astrocytes can contribute to CNS disease pathogenesis and prog...
Main Authors: | Roberta de Ceglia, Andrea Volterra |
---|---|
Format: | Article |
Language: | deu |
Published: |
Swiss Chemical Society
2022-12-01
|
Series: | CHIMIA |
Subjects: | |
Online Access: | https://chimia.ch/chimia/article/view/6172 |
Similar Items
-
Case report: Mixed dementia associated with autoantibodies targeting the vesicular glutamate transporter 2
by: Niels Hansen, et al.
Published: (2023-07-01) -
Expression of Microbial Enzymes in Mammalian Astrocytes to Modulate Lactate Release
by: Barbara Vaccari Cardoso, et al.
Published: (2021-08-01) -
Comparing Viral Vectors and Fate Mapping Approaches for Astrocyte-to-Neuron Reprogramming in the Injured Mouse Cerebral Cortex
by: Matteo Puglisi, et al.
Published: (2024-08-01) -
Genetic Constructs for the Control of Astrocytes’ Activity
by: Anastasia A. Borodinova, et al.
Published: (2021-06-01) -
Vesicular glutamate transporter 2 expression in the ventral tegmental area of outbred male rats following exposure to nicotine and alcohol
by: Maria Vrettou, et al.
Published: (2023-09-01)